NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 308 filers reported holding NATERA INC in Q4 2020. The put-call ratio across all filers is 0.42 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $452,854 | -11.5% | 10,234 | -2.6% | 0.00% | 0.0% |
| Q2 2023 | $511,465 | -15.1% | 10,511 | -3.1% | 0.00% | 0.0% |
| Q1 2023 | $602,392 | +137747.1% | 10,850 | -0.3% | 0.00% | 0.0% |
| Q4 2022 | $437 | -99.9% | 10,882 | -1.1% | 0.00% | 0.0% |
| Q3 2022 | $482,000 | -11.2% | 11,005 | -28.2% | 0.00% | -50.0% |
| Q2 2022 | $543,000 | -19.1% | 15,321 | -7.1% | 0.00% | 0.0% |
| Q1 2022 | $671,000 | -59.4% | 16,490 | -6.9% | 0.00% | -50.0% |
| Q4 2021 | $1,654,000 | -14.3% | 17,712 | +2.2% | 0.00% | -20.0% |
| Q3 2021 | $1,931,000 | +15.4% | 17,329 | +17.6% | 0.01% | +25.0% |
| Q2 2021 | $1,673,000 | +9.3% | 14,734 | -2.2% | 0.00% | 0.0% |
| Q1 2021 | $1,530,000 | +19.4% | 15,070 | +17.1% | 0.00% | 0.0% |
| Q4 2020 | $1,281,000 | +45.1% | 12,869 | +5.3% | 0.00% | +33.3% |
| Q3 2020 | $883,000 | +27.8% | 12,226 | -11.8% | 0.00% | 0.0% |
| Q2 2020 | $691,000 | +225.9% | 13,857 | +94.8% | 0.00% | +200.0% |
| Q1 2020 | $212,000 | – | 7,113 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 797,436 | $35,286,543 | 33.31% |
| Kynam Capital Management, LP | 3,003,668 | $132,912,309 | 21.74% |
| Eversept Partners, LP | 2,492,636 | $110,299,143 | 9.33% |
| Sofinnova Investments, Inc. | 3,100,560 | $137,199,780 | 8.66% |
| Eagle Health Investments LP | 595,694 | $26,359,460 | 5.81% |
| BEACONLIGHT CAPITAL, LLC | 259,865 | $11,499,026 | 4.97% |
| Lagoda Investment Management, L.P. | 165,465 | $7,321,826 | 4.81% |
| Tri Locum Partners LP | 274,795 | $12,159,679 | 3.89% |
| Bain Capital Life Sciences Investors, LLC | 700,197 | $30,983,717 | 3.46% |
| SAMLYN CAPITAL, LLC | 4,400,226 | $194,710,000 | 3.18% |